Business of the House

Barbara Keeley Excerpts

Thursday 18th April 2024 Commons Chamber

[Penny Mordaunt]

My hon. Friend is absolutely right that increasing the number and making sure that every region has medical schools and dental schools is vital, and not just for growing the workforce but for ensuring that the workforce is located where it is required. I will ensure that the Secretary of State has heard what he has said today. My hon. Friend will know that we have had a huge catch-up job to do since the pandemic. We are doing that with 23% more treatments delivered in the last year alone, with an additional 1.7 million adults and 800,000 children receiving NHS dental care, but more needs to be done to ensure that everyone can remain dentally fit.

[Barbara Keeley (Worsley and Eccles South) (Lab)]

Let me join other Members in sending my sympathy to Mr Speaker and his family on the loss of his father, Lord Hoyle.

I have written to the Health Secretary four times on behalf of a constituent to ask why 65 to 69-year-olds have been excluded from the recent so-called “expansion” of the roll-out of the NHS shingles vaccine. Those who are turning 65 are eligible for it, but those already 65 to 69 are missing out and must wait until they are 70 to become eligible, despite the extra vulnerabilities of their age group. Not a single response out of the four from the Minister gave me a straight answer as to why 65 to 69-year-olds are being excluded from this vaccine roll-out. Will the Leader of the House advise me on any other way I can get a clear response from the Minister that lays out clinical or practical reasoning to back up her Department’s decision to exclude 65 to 69-year-olds from the shingles vaccine?

[Penny Mordaunt]

The hon. Lady raises an important question. If the Department had responded to her— I will certainly ask why it has not—the reply would have talked about the step change in the roll-out and how the Department is going to manage the expansion of access to that vaccine. That is understandable, but I know that it is not acceptable to many Members in this House, because from the logic of that it follows that there will be a vaccine available to people who would benefit from it, and the evidence shows that it is clinically effective and cost-effective for those individuals, but they will not be able to access it now. Members are right to press the policy on that front. Obviously, she can raise this issue at questions, but I know it is a concern for a large number of Members and so will make sure that the Secretary of State has heard this and will ask the committees that look at this policy to sense-check what it is doing.